Regenerative Medical Technology Group Inc. income statement RMTG

Annual Quarterly

In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, Regenerative Medical Technology Group Inc. reported revenue of $4.0 million, up 309.1% from the same quarter a year earlier. It recorded a net loss of $2.9 million. Operating income came to $565,977, an operating margin of 14.1%. Diluted earnings per share were -$0.22.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q2 FY2024 Jun 30, 2024	Q1 FY2024 Mar 31, 2024
Revenue	9 +94.3%	4 +309.1%	3 +93.5%	2	1	1 +23.9%	1 +67.0%	1 +119.5%	1 +3.9%
Cost of revenue	4 +138.6%	1 +263.2%	1 +107.6%	1	1	0 +49.3%	0 +69.5%	0 +147.8%	0 -0.5%
Gross profit	6 +72.7%	3 +340.2%	2 +87.1%	1	1	1 +11.2%	1 +65.9%	1 +107.6%	1 +6.0%
Selling, general and administrative	2 +112.2%	1 +198.5%	0 +93.8%	0	0	0 -20.8%	0 +54.4%	0 +5240640.0%	0 +217832.9%
Operating income	0	1 +326.3%	0 +70.3%	-0	-0	-0	0	—	—
Net income	-9 -136.7%	-3 -101.3%	-1 -15.3%	-1	-4	-1 +30.5%	-1 +61.2%	-2 -2.3%	-2 -17.4%
Basic EPS	-0.68 -129.4%	-0.22 -83.3%	-0.07 -16.7%	-0.11	-0.35	-0.12 +29.4%	-0.06 +62.5%	-0.17 -6.3%	-0.16 -23.1%
Diluted EPS	-0.68 -129.4%	-0.22 -83.3%	-0.07 -16.7%	-0.11	-0.35	-0.12 +29.4%	-0.06 +62.5%	-0.17 -6.3%	-0.16 -23.1%
Weighted average shares, basic	13 +3.2%	13 +5.5%	13 +4.8%	13	13	13 +0.4%	13 +0.4%	12 +0.4%	12 +0.4%
Weighted average shares, diluted	13 +3.2%	13 +5.5%	13 +4.8%	13	13	13 +0.4%	13 +0.4%	12 +0.4%	12 +0.4%
Other measures
Depreciation and amortization	0 +116.5%	0 +65.6%	0 +88.5%	0	0	0 -33.9%	0 -32.3%	0 +43.4%	0 +35.2%
EBITDA	0	1 +436.4%	0 +75.3%	-0	-0	-0	0	—	—
Interest coverage	0.00x	0.25x	0.10x	-0.15x	-0.13x	-0.24x	0.15x	—	—
Margins
Gross margin	59.76%	64.09%	66.93%	49.59%	42.49%	59.56%	69.18%	66.41%	69.64%
Operating margin	0.46%	14.07%	8.71%	-19.48%	-37.76%	-25.43%	9.89%	—	—
Profit margin	-93.73%	-72.23%	-33.20%	-88.61%	-368.79%	-146.81%	-55.71%	-261.76%	-240.02%
EBITDA margin	4.32%	16.33%	12.41%	-13.23%	-31.31%	-19.86%	13.69%	—	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Retail-Retail Stores, NEC (SIC 5990)
Listed as: RMTG (OTC)
Fiscal year ends: December 31
Headquarters: Boca Raton, FL
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1760026
Former names: MESO NUMISMATICS, INC. (until Oct 24, 2024)

Other Retail-Retail Stores, NEC companies

JD.com, Inc. JD
Ulta Beauty, Inc. ULTA
Bath & Body Works, Inc. BBWI
Sally Beauty Holdings, Inc. SBH
ATRenew Inc. RERE
Petco Health & Wellness Company, Inc. WOOF
Titan Machinery Inc. TITN
Star Group, L.P. SGU

All 22 Retail-Retail Stores, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.